ZA200200311B - 2-amino-benzoxazinones for the treatment of herpes simplex virus. - Google Patents
2-amino-benzoxazinones for the treatment of herpes simplex virus.Info
- Publication number
- ZA200200311B ZA200200311B ZA200200311A ZA200200311A ZA200200311B ZA 200200311 B ZA200200311 B ZA 200200311B ZA 200200311 A ZA200200311 A ZA 200200311A ZA 200200311 A ZA200200311 A ZA 200200311A ZA 200200311 B ZA200200311 B ZA 200200311B
- Authority
- ZA
- South Africa
- Prior art keywords
- benzoxazinones
- amino
- treatment
- herpes simplex
- simplex virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14295699P | 1999-07-12 | 1999-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200200311B true ZA200200311B (en) | 2003-01-14 |
Family
ID=22501956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200200311A ZA200200311B (en) | 1999-07-12 | 2002-01-14 | 2-amino-benzoxazinones for the treatment of herpes simplex virus. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1210088A4 (en) |
| JP (1) | JP2003504334A (en) |
| KR (1) | KR20020046273A (en) |
| CN (1) | CN1481245A (en) |
| AU (2) | AU774370B2 (en) |
| BR (1) | BR0012380A (en) |
| CA (1) | CA2378014A1 (en) |
| HK (1) | HK1046862A1 (en) |
| MX (1) | MXPA02000485A (en) |
| WO (1) | WO2001003697A1 (en) |
| ZA (1) | ZA200200311B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879846B2 (en) * | 2006-09-21 | 2011-02-01 | Kyorin Pharmaceutical Co.., Ltd. | Serine hydrolase inhibitors |
| EP4144336A1 (en) * | 2021-05-14 | 2023-03-08 | The Procter & Gamble Company | Wet wipes with a cellulosic substrate and gentle lotion |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985872A (en) * | 1995-05-24 | 1999-11-16 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
-
2000
- 2000-07-11 AU AU62089/00A patent/AU774370B2/en not_active Ceased
- 2000-07-11 CN CNA008164517A patent/CN1481245A/en active Pending
- 2000-07-11 MX MXPA02000485A patent/MXPA02000485A/en unknown
- 2000-07-11 WO PCT/US2000/018817 patent/WO2001003697A1/en not_active Application Discontinuation
- 2000-07-11 JP JP2001508977A patent/JP2003504334A/en not_active Withdrawn
- 2000-07-11 EP EP00948615A patent/EP1210088A4/en not_active Withdrawn
- 2000-07-11 CA CA002378014A patent/CA2378014A1/en not_active Abandoned
- 2000-07-11 BR BR0012380-3A patent/BR0012380A/en not_active IP Right Cessation
- 2000-11-07 KR KR1020027000487A patent/KR20020046273A/en not_active Application Discontinuation
-
2002
- 2002-01-14 ZA ZA200200311A patent/ZA200200311B/en unknown
- 2002-11-22 HK HK02108474.6A patent/HK1046862A1/en unknown
-
2004
- 2004-08-13 AU AU2004203884A patent/AU2004203884A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6208900A (en) | 2001-01-30 |
| JP2003504334A (en) | 2003-02-04 |
| AU774370B2 (en) | 2004-06-24 |
| BR0012380A (en) | 2002-08-27 |
| WO2001003697A1 (en) | 2001-01-18 |
| EP1210088A1 (en) | 2002-06-05 |
| CA2378014A1 (en) | 2001-01-18 |
| EP1210088A4 (en) | 2003-03-12 |
| CN1481245A (en) | 2004-03-10 |
| HK1046862A1 (en) | 2003-01-30 |
| MXPA02000485A (en) | 2004-09-10 |
| AU2004203884A1 (en) | 2004-09-09 |
| KR20020046273A (en) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
| HK1048073A1 (en) | Use of xenon for treating neurointoxications. | |
| ZA200202461B (en) | Compounds for the treatment of ischemia. | |
| ZA9811507B (en) | Combination effective for the treatment of impotence. | |
| ZA200202822B (en) | Oncolytic combinations for the treatment of cancer. | |
| GB9709360D0 (en) | Methods for the treatment of herpes virus infections | |
| ZA973622B (en) | Use of forms of hyaluronic acid (HA) for the treatment of cancer. | |
| AU2001260834A1 (en) | The treatment of herpes | |
| ZA200105690B (en) | Novel treatment. | |
| AU1916601A (en) | Oncolytic combinations for the treatment of cancer | |
| ZA200108392B (en) | Process for the preparation of substituted pyrimidines. | |
| AU1916501A (en) | Oncolytic combinations for the treatment of cancer | |
| ZA200110539B (en) | Oxazinocarbazoles for the treatment of CNS diseases. | |
| ZA200205470B (en) | Virus strains for the oncolytic treatment of cancer. | |
| AU1917101A (en) | Oncolytic combinations for the treatment of cancer | |
| AU1595001A (en) | Oncolytic combinations for the treatment of cancer | |
| ZA200200311B (en) | 2-amino-benzoxazinones for the treatment of herpes simplex virus. | |
| ZA200203166B (en) | Treatment of cancer. | |
| HK1050533A1 (en) | Substituted pyrroles as antiproliferative agents for the treatment of cancer. | |
| AU1595101A (en) | Oncolytic combinations for the treatment of cancer | |
| MXPA01013023A (en) | Therapeutic agents. | |
| MXPA03004454A (en) | Imidazolone derivatives for the treatment of viral diseases. | |
| ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
| MXPA01010701A (en) | Vaccine. | |
| AU6896300A (en) | Vaccines for the treatment of autoimmune disease |